Global
Antibiotics Market 2014-2018 is the latest addition
to Sandlerresearch.org industry research reports collection.
Antibacterial drugs are chemical compounds used to kill or inhibit the
growth of bacteria. The term “antibiotic” is often used synonymously with
antibacterial; however, the term “antibiotic” was originally coined to refer to
the antibacterial compounds of microbial origin. Antibacterial acts via various
mechanisms such as the inhibition of cell wall synthesis, the inhibition of
nucleic acid synthesis, the disruption of the cell membrane, and the inhibition
of protein synthesis. It can be bacteriostatic or bactericidal in nature.
Antibiotics are medicines that are used to treat infections caused by bacteria
(e.g., respiratory tract infections). Antibiotics work against microorganisms
such as bacteria, fungi, and parasites but are not effective against viruses.
Antibiotics either block vital processes in bacteria, kill the bacteria, or
halt them from growing. Antibiotics that affect a wide range of bacteria are
called broad spectrum antibiotics (e.g., amoxicillin and gentamicin).
Antibiotics that affect only a few types of bacteria are called narrow spectrum
antibiotics (e.g., penicillin).
Analysts forecast the Global Antibiotics
market to grow at a CAGR of 1.41 percent over the period
2013-2018.
The report recognizes the following companies as the key players in the
Global Antibiotics Market: AstraZeneca plc, Eli Lilly & Co.,
GlaxoSmithKline plc, Johnson & Johnson Ltd., Novartis AG, Pfizer Inc. and
Sanofi.
Other Prominent Vendors in the market are: Bayer HealthCare,
Bristol-Myers Squibb, Cubist Pharmaceuticals, Daiichi Sankyo, F. Hoffmann-La
Roche and Takeda Pharmaceutical.
One key trend emerging in this market is the increase in demand for
antibiotics, which is attracting various companies to the pharmaceutical space.
The increase in demand for antibiotics to counter growing cases of
drug-resistant infections offers ideal opportunities for pharmaceutical
companies to introduce new products into the marketplace.
Covered in this
Report
This report covers the present scenario and the growth prospects of the
Global Antibiotics market for the period 2014-2018. To calculate the market
size, the report considers the revenue generated from the sales of various
antibiotics for human use. The Global Antibiotics market can be divided into
eight segments: Beta-lactams, Macrolides, Aminoglycosides, Phenicols,
Quinolones, Sulfonamides, Tetracyclines, and Others.
Global Antibiotics Market 2014-2018, has been prepared based on an
in-depth market analysis with inputs from industry experts. The report covers
the Americas, and the APAC and EMEA regions; it also covers the Global
Antibiotics market landscape and its growth prospects in the coming years. The
report includes a discussion of the key vendors operating in this market.
According to the report, one of the main drivers in this market is the
increasing global aging population. The elderly are more likely to acquire
infections and require hospitalization. The elderly are more prone to
hospital-acquired infections. Therefore, more treatment options, including
antibiotics, are needed to meet the treatment requirements of the growing
elderly population.
Further, the report states that one of the main challenges that this
market confronts is the emergence of drug-resistant strains. These
drug-resistant infectious agents can easily spread to other regions as they are
able to persist inside the human body despite treatment with standard
therapies.
Single User License of the Report is Available
at USD 2500, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=23277 .
